Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Berger AC, Watson JC, Ross EA, Hoffman JP.

Am Surg. 2004 Mar;70(3):235-40; discussion 240.

PMID:
15055847
2.

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.

Surgery. 2007 May;141(5):610-8. Epub 2007 Mar 23.

PMID:
17462460
3.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74. Epub 2007 Sep 26.

PMID:
17896141
4.

Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P.

Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4. Epub 2008 Aug 20.

PMID:
18712568
5.

Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.

J Clin Oncol. 2005 Dec 1;23(34):8706-12.

PMID:
16314630
6.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
7.

The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.

Hellan M, Sun CL, Artinyan A, Mojica-Manosa P, Bhatia S, Ellenhorn JD, Kim J.

Pancreas. 2008 Jul;37(1):19-24. doi: 10.1097/MPA.0b013e31816074c9.

PMID:
18580439
8.

Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.

Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, Jaques BC, Charnley RM, White SA.

Eur J Surg Oncol. 2012 Apr;38(4):333-9. doi: 10.1016/j.ejso.2011.12.020. Epub 2012 Feb 7.

PMID:
22317758
9.

Does lymph node ratio impact survival in resected periampullary malignancies?

Hurtuk MG, Hughes C, Shoup M, Aranha GV.

Am J Surg. 2009 Mar;197(3):348-52. doi: 10.1016/j.amjsurg.2008.11.010.

PMID:
19245913
10.

Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.

Kang MJ, Jang JY, Chang YR, Kwon W, Jung W, Kim SW.

Ann Surg Oncol. 2014 May;21(5):1545-51. doi: 10.1245/s10434-013-3473-9. Epub 2014 Jan 14.

PMID:
24419758
11.

lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.

Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.

PMID:
19289261
12.

The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.

Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer Study (GIRCG).

Eur J Surg Oncol. 2008 Feb;34(2):159-65. Epub 2007 Jun 13.

PMID:
17566691
13.

Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.

Shamseddine AI, Mukherji D, Melki C, Elias E, Eloubeidi M, Dimassi H, Khalife M, Abou-Alfa G, O'Reilly E, Faraj W.

Am J Clin Oncol. 2014 Feb;37(1):13-8. doi: 10.1097/COC.0b013e31826b9c74.

PMID:
23111358
14.

The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Peschaud F, Benoist S, Julié C, Beauchet A, Penna C, Rougier P, Nordlinger B.

Ann Surg. 2008 Dec;248(6):1067-73. doi: 10.1097/SLA.0b013e31818842ec. Erratum in: Ann Surg. 2009 Apr;249(4):701.. Frederique, Peschaud [corrected to Peschaud, Frederique]; Stephane, Benoist [corrected to Benoist, Stephane]; Catherine, Julié [corrected to Julié, Catherine]; Alain, Beauchet [corrected to Beauchet, Alain]; Christophe, Penna [corrected to Penna, Christo.

PMID:
19092352
15.

Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S.

Ann Surg Oncol. 2008 Nov;15(11):3118-23. doi: 10.1245/s10434-008-0123-8. Epub 2008 Sep 3.

PMID:
18769971
16.

Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Lee SD, Kim TH, Kim DY, Baek JY, Kim SY, Chang HJ, Park SC, Park JW, Oh JH, Jung KH.

Eur J Surg Oncol. 2012 Jun;38(6):478-83. doi: 10.1016/j.ejso.2012.03.002. Epub 2012 Mar 30.

PMID:
22465588
17.
18.

Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.

La Torre M, Cavallini M, Ramacciato G, Cosenza G, Rossi Del Monte S, Nigri G, Ferri M, Mercantini P, Ziparo V.

J Surg Oncol. 2011 Nov 1;104(6):629-33. doi: 10.1002/jso.22013. Epub 2011 Jun 28.

PMID:
21713779
19.

Metastatic lymph node size and colorectal cancer prognosis.

Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H, Kubota H, Nagasue N.

J Am Coll Surg. 2005 Jan;200(1):20-8.

PMID:
15631916
20.

Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.

Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C.

Ann Surg Oncol. 2007 May;14(5):1712-7. Epub 2007 Jan 26.

PMID:
17253102

Supplemental Content

Support Center